Introduction:

Coronaviruses infect humans and may cause neurological manifestations in susceptible individuals.

Objective:

Describe the pathogenesis of neurological manifestations in patients with COVID-19.

Search strategy and selection criteria:

A review was conducted of national and international updated bibliography. The search was carried out in Google Scholar and open access papers were consulted in the databases PubMed and SciELO from January 2014 to 6 May 2020. A total 51 papers (6 in Spanish and 45 in English) and a book on neuroimmunology were selected. The search terms used were “COVID-19”, “coronavirus”, “SARS-CoV-2”, “neurological manifestations”, “nervous system” and “pathogenesis”, in compliance with the Health Sciences Descriptors (DeCS).

Data analysis and integration:

SARS-CoV-2 enters the nervous system by lymphatic, hematogenous, transynaptic, retrograde routes, by local dissemination through the ethmoid, or by dysfunction of the hematoencephalic barrier. Pathogenesis may be due to direct action by the virus or immunomediated. During the COVID-19 pandemic patients have been reported with central, peripheral and musculoskeletal neurological manifestations. The most common symptoms are taste and smell disorders, headache, myalgia and dizziness. Meningitis, encephalitis, Guillain-Barré syndrome, stroke and encephalopathies have been reported in severe forms of the disease.

Conclusions:

SARS-CoV-2 may affect the central and the peripheral nervous system. It mainly causes mild, transient manifestations, but neurological complications may also occur. The main pathogenic mechanisms are direct cytophatic damage or indirect mechanisms resulting from an inflammatory response.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )